Related Experiment Video
Updated: May 26, 2026

10:13
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Tuning PI3K: striking the right balance for optimal CD8 T-cell responses.
Jennifer L Cannons1, Andrea C Pichler1, Pamela L Schwartzberg1
1Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.
Journal of Immunology (Baltimore, Md. : 1950)
|May 24, 2026
Summary
Phosphatidylinositol 3-kinases (PI3Ks), particularly PI3Kδ, are crucial for CD8 T-cell responses. Understanding PI3Kδ signaling is vital for addressing viral infections, cancer, and immune deficiencies.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- CD8 cytolytic T cells are essential for eliminating viral infections and tumor cells.
- T-cell activation, differentiation, and function are regulated by signaling pathways.
- CD8 T-cell exhaustion, a state of hyporesponsiveness, occurs with chronic antigen exposure.
Purpose of the Study:
- To review the critical role of phosphatidylinositol 3-kinases (PI3Ks) in CD8 T-cell responses.
- To focus on the specific function of PI3Kδ in CD8 T-cell activation, differentiation, and effector functions.
- To explore downstream effectors and insights from PI3K pathway mutants.
Main Methods:
- Literature review focusing on PI3K signaling in CD8 T cells.
- Analysis of studies involving mouse models with PI3K pathway mutations.
- Examination of data from primary immunodeficiencies linked to PI3K signaling.
Main Results:
- PI3Kδ plays a significant role in CD8 T-cell activation and differentiation into effector and memory populations.
- Dysregulation of PI3K signaling contributes to CD8 T-cell exhaustion in chronic infections and cancer.
- Mutant PI3K pathways in mouse models and human immunodeficiencies provide insights into T-cell function.
Conclusions:
- PI3Kδ is a key regulator of CD8 T-cell immunity, impacting responses to infections and cancer.
- Targeting PI3Kδ pathways may offer therapeutic strategies for immune modulation.
- Further research into PI3K signaling is crucial for understanding and treating immune-related disorders.

